PITTSBURGH, June 12, 2025 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (NASDAQ: POAI), a leader in AI-driven drug discovery, announced today the company has successfully developed 3D organoid models ...
To help meet the potentially complex needs of patients after prostate cancer treatment and offer the precision and care ...
PITTSBURGH, May 22, 2025 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (NASDAQ: POAI) moves to leverage its vast biobank of more than 150,000 heterogenous live cell tumor samples and drug response data ...
Overview: Predictive analytics is about action, not just forecasts. The best platforms explain trends and guide what to do ...
BostonGene, the developer of the leading AI foundation model for tumor and immune biology, today announced a strategic collaboration with AstraZeneca, a global, science-led biopharmaceutical company ...
Forbes contributors publish independent expert analyses and insights. David Henkin helps organizations and individuals innovate and grow. Predictive analytics has evolved from a niche discipline into ...
"Driven by EHR adoption, cost-efficiency goals, and IoT integration, the healthcare predictive analytics market is reshaping ...
The cancer research company has adopted a digital asset treasury model centered on decentralized physical infrastructure networks. Update (Oct. 1, 00:30 UTC): This article has been updated to include ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback